Top 15 Global Corporations, 2009, Total Audited Markets

2009 rank 2009 Sales (US$ 2008 Sales (US$ 2007 Sales (US$ 2006 Sales (US$ 2005 Sales (US$
(US$) MN) MN) MN) MN) MN)

Global Market 0 $ 752,022 $ 727,067 $ 671,164 $ 609,614 $ 568,047

PFIZER 1 $ 57,024 $ 58,677 $ 59,909 $ 59,415 $ 59,204
MERCK & CO 2 $ 38,963 $ 39,488 $ 39,365 $ 35,965 $ 33,676
NOVARTIS 3 $ 38,460 $ 36,684 $ 34,479 $ 31,653 $ 29,427
SANOFI-AVENTIS 4 $ 35,524 $ 36,437 $ 34,390 $ 31,843 $ 31,286
GLAXOSMITHKLINE 5 $ 34,973 $ 36,736 $ 37,620 $ 36,212 $ 34,222
ASTRAZENECA 6 $ 34,434 $ 32,498 $ 29,999 $ 27,311 $ 24,420
ROCHE 7 $ 32,763 $ 30,285 $ 27,232 $ 23,168 $ 19,706
JOHNSON & JOHNSON 8 $ 26,783 $ 29,638 $ 29,010 $ 27,615 $ 26,771
LILLY 9 $ 20,310 $ 19,042 $ 17,177 $ 15,176 $ 13,977
ABBOTT 10 $ 19,840 $ 19,401 $ 17,359 $ 15,971 $ 14,715
TEVA 11 $ 15,947 $ 15,143 $ 13,295 $ 11,664 $ 9,677
BAYER 12 $ 15,711 $ 15,887 $ 14,103 $ 12,329 $ 11,588
BOEHRINGER INGEL 13 $ 15,275 $ 14,109 $ 12,556 $ 11,320 $ 10,385
AMGEN 14 $ 15,038 $ 15,281 $ 15,900 $ 15,932 $ 13,162
TAKEDA 15 $ 14,352 $ 13,835 $ 12,754 $ 11,786 $ 11,265

Source: IMS Health Midas, December 2009

US$: Sales and Rank are in US$ with quarterly exchange rates
Sales cover direct and indirect pharmaceutical channel wholesalers and manufacturers. The figures above include
prescription and certain over the counter data and represent manufacturer prices.